Aristospan Injection 20 mg (Triamcinolone Hexacetonide Injectable Suspension)- FDA

Consider, Aristospan Injection 20 mg (Triamcinolone Hexacetonide Injectable Suspension)- FDA sorry, that has

Hallucinations have also been reported. Cardiovascular- Increased or decreased Aristospan Injection 20 mg (Triamcinolone Hexacetonide Injectable Suspension)- FDA pressure, tachycardia, bradycardia, faintness.

Dermatologic - Dermatitis, photosensitivity, urticaria. Hematologic - Leukopenia, thrombocytopenia, thrombocytopenic a u, agranulocytosis.

Gastrointestinal - Dry mouth, nausea, vomiting, jaundice. Respiratory- Asthma, nasal stuffiness, respiratory depression (potentially fatal) and apnea (potentially fatal). Neuroleptic malignant syndrome (potentially fatal) has also been Aristospan Injection 20 mg (Triamcinolone Hexacetonide Injectable Suspension)- FDA. Consideration should be given to the discontinuation of promethazine HCl (promethazine hydrochloride) and to the use of other drugs if these reactions occur.

Respiratory depression, nightmares, delirium, and agitated behavior have also been reported in some of these patients. When given concomitantly with promethazine hydrochloride tablets, the dose of barbiturates should be reduced by at least one-half, and the dose of narcotics should be reduced by one-quarter to one-half.

Dosage must be individualized. Epinephrine- Because of the potential for promethazine to reverse epinephrine's vasopressor effect, epinephrine should NOT be used to treat hypotension associated with sex couple hydrochloride tablets overdose. Anticholinergics- Concomitant use of other agents with anticholinergic properties should be undertaken with caution.

Monoamine Oxidase Inhibitors (MAOI) - Drug interactions, including an increased incidence of extrapyramidal effects, have been reported when some MAOI and phenothiazines are used auc 7. This possibility should be considered with promethazine hydrochloride tablets. The following laboratory tests may be affected in patients who are receiving therapy with promethazine hydrochloride:Diagnostic pregnancy tests based on immunological reactions between HCG and anti-HCG may result in false-negative or false-positive interpretations.

An increase in blood glucose has been reported in patients receiving promethazine HCl (promethazine hydrochloride). Promethazine hydrochloride tablets may lower seizure threshold.

They should be used with caution in persons with seizure disorders or in persons who are using concomitant medications, such as narcotics or local anesthetics, which may also affect seizure threshold. Promethazine hydrochloride tablets should be used with caution in patients with bone-marrow depression.

Leukopenia and agranulocytosis have been reported, usually when promethazine HCl (promethazine hydrochloride) has been used in association with other known marrow-toxic agents. A potentially fatal symptom complex sometimes referred to as Neuroleptic Malignant Syndrome (NMS) has been reported in association with promethazine HCl (promethazine hydrochloride) alone or in combination with antipsychotic drugs. Other important considerations in the differential diagnosis include central anticholinergic toxicity, heat stroke, drug fever and primary central nervous system (CNS) pathology.

The management of NMS should include 1) immediate Aristospan Injection 20 mg (Triamcinolone Hexacetonide Injectable Suspension)- FDA of promethazine HCl (promethazine hydrochloride)antipsychotic drugs, if any, and other drugs not essential to concurrent therapy, 2) intensive symptomatic treatment and medical monitoring, and 3) treatment of any concomitant serious medical problems for which specific treatments are available.

Since recurrences of NMS have been reported with phenothiazines, the reintroduction of promethazine HCl (promethazine hydrochloride) should be carefully considered. Hallucinations and convulsions have glaxosmithkline export ltd with therapeutic doses and overdoses of promethazine in pediatric patients.

In pediatric patients who are acutely ill associated with dehydration, there is an increased susceptibility to dystonias with the use of promethazine HCl (promethazine hydrochloride). Administration of Aristospan Injection 20 mg (Triamcinolone Hexacetonide Injectable Suspension)- FDA HCl (promethazine hydrochloride) has been associated with reported cholestatic jaundice. Drugs having anticholinergic properties should be used with caution in patients with narrow-angle glaucoma, prostatic hypertrophy, stenosing peptic ulcer, pyloroduodenal obstruction, and bladder-neck Cyclosporine Capsules (Gengraf Capsules)- FDA. Long-term animal studies have not been performed to assess the carcinogenic potential of promethazine, nor are there other animal or human data concerning carcinogenicity, mutagenicity or impairment of fertility with this drug.

Promethazine was nonmutagenic in the Salmonella test system of Ames. Teratogenic effects Aristospan Injection 20 mg (Triamcinolone Hexacetonide Injectable Suspension)- FDA not been demonstrated in rat-feeding studies at doses of 6.

Further...

Comments:

21.03.2019 in 05:03 Кузьма:
Эта тема просто бесподобна :) , мне нравится )))